Integrator complex removes lesion-stalled RNA polymerase II after transcription-coupled repair to facilitate transcription restart
Open accessThe DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index; none of the 177 sources its claims cite is checked for support yet.
Abstract
Gene transcription by RNA Polymerase II (Pol II) is highly vulnerable to transcription-blocking DNA lesions (TBLs), which, if unresolved, induce transcription stress leading to cellular decline and aging. TBLs are removed by transcription-coupled nucleotide excision repair (TC-NER). TC-NER is initiated when Cockayne syndrome group B protein recognizes lesion-stalled Pol II and promotes TC-NER complex assembly. This complex recruits TFIIH for lesion verification, followed by incision and repair to enable transcription restart. Many TBLs stall Pol II within its active site, shielding the lesion from repair and requiring Pol II processing to expose it. However, whether this occurs through Pol II backtracking or release from the DNA, and the regulatory mechanisms involved, remain poorly defined. Here, we identified the Integrator complex as a key factor in lesion-stalled Pol II processing. Interaction proteomics revealed Integrator recruitment to late-stage TC-NER complexes. Integrator’s endonuclease core promotes efficient transcription recovery after TBL induction, without affecting lesion removal by TC-NER. Live-cell imaging and chromatin retention assays demonstrated that Integrator facilitates Pol II release from DNA following TC-NER. Collectively, these findings support a two-step mechanism for Pol II clearance during TC-NER, wherein TFIIH-mediated backtracking exposes the lesion for repair, followed by Integrator-mediated Pol II release to restore transcription.
Overview
CoChat Summary
TL;DR
The Integrator complex is recruited to late-stage TC-NER complexes, and its endonuclease core promotes transcription recovery after transcription-blocking lesions without affecting TC-NER-mediated repair. It acts after TFIIH-dependent lesion exposure to release previously lesion-stalled Pol II from chromatin, supporting a two-step Pol II clearance model.
Key findings
- Interaction proteomics identified Integrator as a top factor with reduced binding to transcriptionally engaged Pol II in STK19 KO cells after UV; 13 of 15 quantified Integrator subunits were reduced similarly to UVSSA and TFIIH. INTS11 immunoprecipitation from chromatin showed UV-induced interaction with CSB, CSA, XPB, and XPD, which was lost upon NAEi or spironolactone treatment.
- INTS11 depletion severely impaired transcription recovery after UV (8 J/m²) and Illudin S, comparable to CSB depletion; INTS9 depletion gave similar results, and catalytic-inactive INTS11 E203Q failed to rescue whereas WT INTS11 did. Recovery after flavopiridol washout was unaffected.
- INTS11 was dispensable for TC-NER repair: CSB FRAP remobilization, Pol II ubiquitylation, TFIIH recruitment to elongating Pol II, trabectedin-induced ssDNA breaks, and TCR-UDS were all normal in INTS11-depleted cells.
- INTS11 depletion increased the UV-induced immobile Pol II fraction by ∼50% and left pSer2 Pol II largely unchanged, whereas WT cells showed a ∼50% decrease; DRB run-off showed delayed release of lesion-stalled Pol II at local UV damage. No such effect was seen in UVSSA KO, spironolactone-treated, or formaldehyde/DPC conditions, while XPA KO cells still depended on INTS11.
Methods
- Cell lines and perturbations: HCT116, RPE1, and HeLa cells, including Halo-HA-INTS11 KI, GFP-RPB1 KI, CSB-mScarletI KI, and TC-NER KO lines; treatments included UV-C, Illudin S, trabectedin, formaldehyde, flavopiridol, PROTAC3, siRNA/shRNA, and inhibitors.
- Proteomics and biochemical assays: SILAC-based interaction proteomics of pSer2-modified Pol II in WT versus STK19 KO cells after UV, chromatin fractionation, immunoprecipitation, and immunoblotting.
- Functional assays: EU incorporation for nascent transcription/recovery, FRAP live-cell imaging, flow cytometry, immunofluorescence, alkaline comet assay, TCR-UDS, and local DRB run-off; statistics used unpaired two-tailed t-tests.
Limitations
- Stated: Integrator depletion only partially affects Pol II removal, suggesting additional parallel clearance mechanisms such as XRN2, TTF2, PCF11, and RPRD1B; the authors cannot exclude that Integrator recognizes a stalled, non-productive TC-NER intermediate independent of productive Pol II backtracking; local transcription restart at the repair site cannot be ruled out.
- Stated: residual INTS11 after PROTAC3-mediated depletion may explain the less severe transcription recovery defect after Illudin S compared with CSB KO cells.
- Evident from the text: the TFIIH-mediated backtracking step is inferred from dependency on TFIIH/STK19 and from the absence of an INTS11 effect in DPC/UVSSA KO conditions, rather than directly visualized; many conclusions rely on depletion/rescue and imaging assays.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures











Verification
Claims the paper makes
0 Valid · 0 Not valid · 79 Not checked · 154 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Binding of all quantified Integrator complex subunits (13 out of 15) to transcriptionally engaged Pol II in response to UV damage was reduced to a similar extent as that of UVSSA and TFIIH subunits.”
§ Integrator complex removes lesion-stalled RNA polymerase II after transcription-coupled repair to facilitate transcription restart > Results > Integrator complex interacts with elongating Pol II and the TC-NER machinery
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interestingly, gene ontology (GO) analysis revealed that, alongside these TC-NER factors, the Integrator complex was the top factor with reduced Pol II binding in STK19 KO cells (Fig. 1C and Supplementary Fig. S1A and B).”
§ Integrator complex removes lesion-stalled RNA polymerase II after transcription-coupled repair to facilitate transcription restart > Results > Integrator complex interacts with elongating Pol II and the TC-NER machinery
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interaction proteomics revealed Integrator recruitment to late-stage TC-NER complexes.”
- Also stated in: § Introduction · plain
“We identified the Integrator complex as a DNA damage-induced interactor of late-stage TC-NER complexes.”
§ Integrator complex removes lesion-stalled RNA polymerase II after transcription-coupled repair to facilitate transcription restart > Abstract
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Introduction · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Live-cell imaging and chromatin retention assays demonstrated that Integrator facilitates Pol II release from DNA following TC-NER.”
- Also stated in: § Introduction · plain
“Instead, the Integrator complex facilitates eviction of Pol II after repair has taken place, to enable efficient transcription recovery.”
§ Integrator complex removes lesion-stalled RNA polymerase II after transcription-coupled repair to facilitate transcription restart > Abstract
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Introduction · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As previously described, binding of the TC-NER factors UVSSA and TFIIH was severely impaired in STK19 KO cells (Fig. 1A and B).”
§ Integrator complex removes lesion-stalled RNA polymerase II after transcription-coupled repair to facilitate transcription restart > Results > Integrator complex interacts with elongating Pol II and the TC-NER machinery
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
131 more claims
Create a free account to see all 233 claims and to verify the 177 references still open.
- It may state two separate claims as one. 65
- Probably not a substantial claim. 45
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Integrator complex removes lesion-stalled RNA polymerase II after transcription-coupled repair to facilitate transcription restart > Results > INTS11 promotes removal of Pol II at TC-NER damage sites
“after FA treatment (1 µM, 30 min)”
§ Integrator complex removes lesion-stalled RNA polymerase II after transcription-coupled repair to facilitate transcription restart > Materials and methods > Treatment with DNA-damaging agents and inhibitors
“exposing cells to 1 mM formaldehyde (FA, Pierce, 16% methanol-free solution, Thermo Scientific) for 30 min, after which the compound was quenched by three washes in culture medium for recovery of RNA synthesis (RRS).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Integrator complex removes lesion-stalled RNA polymerase II after transcription-coupled repair to facilitate transcription restart > Results > INTS11 promotes TC-NER-mediated transcription recovery
“after Illudin S-induced damage (75 ng/ml for 2.5 h)”
§ Integrator complex removes lesion-stalled RNA polymerase II after transcription-coupled repair to facilitate transcription restart > Materials and methods > Treatment with DNA-damaging agents and inhibitors
“cells were treated with Illudin S (75 ng/ml; I019, TOKU-E) for 2 h”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Integrator complex removes lesion-stalled RNA polymerase II after transcription-coupled repair to facilitate transcription restart > Results > INTS11 facilitates Pol II processing at TBLs
“Cycloheximide (100 μM) was added 2 h prior to UV-irradiation and maintained for the duration of the experiment.”
§ Integrator complex removes lesion-stalled RNA polymerase II after transcription-coupled repair to facilitate transcription restart > Materials and methods > Immunofluorescence
“Cells were treated with 100 μM cycloheximide 1 h prior to treatment and remained in the medium for the duration of Pol II degradation assays.”
Citations
Cites
Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment
Cox, J., Neuhauser, N., Michalski, A., Scheltema, R. A., Olsen, J. V., & Mann, M. (2011) · Journal of Proteome Research · doi:10.1021/pr101065j · Cited by 5,500
Understanding nucleotide excision repair and its roles in cancer and ageing
Marteijn, J. A., Lans, H., Vermeulen, W., & Hoeijmakers, J. H. J. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3822 · Cited by 1,192
Self-citationTranscription-coupled DNA repair: two decades of progress and surprises
Hanawalt, P. C., & Spivak, G. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2549 · Cited by 1,044
Getting up to speed with transcription elongation by RNA polymerase II
Jonkers, I., & Lis, J. T. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3953 · Cited by 876
Targeting transcription regulation in cancer with a covalent CDK7 inhibitor
Kwiatkowski, N., Zhang, T., Rahl, P. B., Abraham, B. J., Reddy, J., Ficarro, S. B., Dastur, A., Amzallag, A., Ramaswamy, S., Tesar, B., et al. (2014) · Nature · doi:10.1038/nature13393 · Cited by 855
Protein neddylation: beyond cullin–RING ligases
Enchev, R. I., Schulman, B. A., & Peter, M. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3919 · Cited by 615
Inhibiting eukaryotic transcription: which compound to choose? How to evaluate its activity
Bensaude, O. (2011) · Transcription · doi:10.4161/trns.2.3.16172 · Cited by 574
Baillat, D., Hakimi, M.-A., Näär, A. M., Shilatifard, A., Cooch, N., & Shiekhattar, R. (2005) · Cell · doi:10.1016/j.cell.2005.08.019 · Cited by 545
HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins
Buckley, D. L., Raina, K., Darricarrere, N., Hines, J., Gustafson, J. L., Smith, I. E., Miah, A. H., Harling, J. D., & Crews, C. M. (2015) · ACS Chemical Biology · doi:10.1021/acschembio.5b00442 · Cited by 488
Flavopiridol Inhibits P-TEFb and Blocks HIV-1 Replication
Chao, S.-H., Fujinaga, K., Marion, J. E., Taube, R., Sausville, E. A., Senderowicz, A. M., Peterlin, B. M., & Price, D. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000446200 · Cited by 455
Cited by
Still being checked.
Metadata
- Authors
- Blom, C. M. A., Gómez-Vázquez, E., van Sluis, M., & Marteijn, J. A.
- Affiliations
- Erasmus MC (NL)
- Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center , 3015 GD,Rotterdam ,
- Corresponding author
- Marteijn, Jurgen A
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2026-10-24
- Volume
- 54
- Issue
- 20
- Pages
- gkag1068
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC13722877
- OpenAlex
- W7224996954
- Cited by
- 0
- References
- 113
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, cc-by)
- Funders
- Dutch Cancer Society (14817)
- Netherlands Organization for Scientific Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Keywords
- Integrator complex, RNA polymerase II, transcription-coupled repair, TFIIH, aging
- MeSH terms
- Excision Repair, DNA Damage, DNA Repair, DNA-Binding Proteins, Humans, RNA Polymerase II, Transcription Factors, Transcription, Genetic, Transcription Factor TFIIH
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-22, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-22 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Integrator complex removes lesion-stalled RNA polymerase II after transcription-coupled repair to facilitate transcription restart. https://app.cochat.ai/papers/10.1093/nar/gkag1068
- The paper
- Blom, C. M. A., Gómez-Vázquez, E., van Sluis, M., & Marteijn, J. A. (2026). Integrator complex removes lesion-stalled RNA polymerase II after transcription-coupled repair to facilitate transcription restart. Nucleic Acids Research. https://doi.org/10.1093/nar/gkag1068
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.